1RW Johnson Pharmaceutical Research Institute, Route 202-Box 300, Raritan, NJ 08869-0602, USA. kbush@prius.jnj.com
Developing new antimicrobial agents against multi-resistant Gram-positive bacteria is crucial. Promising drug classes include streptogramins, glycopeptides, oxazolidinones, and quinolones, with novel targets under investigation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: